26 Apr 2021
Today I’m speaking with Professor Danny Altmann from Imperial College about Covid-19 and the post viral syndrome associated with its infection currently referred to as “Long Covid”. Not a lot is known about this chronic condition which for some people is absolutely debilitating, it could affect 500,000 people in the UK or more and we really need to further research this condition and build the infrastructure to tackle it.
Professor Altmann heads a lab at the Hammersmith Hospital Campus of Imperial. Key research interests are the immunology of infectious disease including severe bacterial infections, Zika virus and Chikungunya virus. Other projects focus on autoimmune disease including the role of the microbiota in rheumatoid arthritis.
Today we refresh our memories about what we know about covid:
We would love to get your feedback on the subject matter of these episodes - please do let me know on our social media pages (Instagram, Facebook & Twitter) what you think,and give us a 5* rating on your podcast player if you enjoyed today’s episode
And don’t forget to subscribe to The Doctor’s Kitchen newsletter for weekly science based recipes and tips to help you live the healthiest and happiest lifestyle possible.
It was a real pleasure to speak with Professor Danny Altmann on the podcast to talk about this really topical subject - I hope you found it as interesting as I did and weve added some links below to a few articles for reference and further reading:
Do watch out for another two podcast episodes on Long Covid this week too!
Immune determinants of COVID
Prof Altman on Long Covid (BMJ)
50 long term effects of Long Covid
Danny Altmann is a Professor of Immunology who has been based at the Hammersmith Hospital campus of Imperial College since 1994. He runs an immunology research lab which has a focus on HLA genes, T cells and NK cells in autoimmunity and infectious disease. Many of the research projects are run collaboratively with Professor Rosemary Boyton as co-PI The research lab has expertise in the HLA system, antigen discovery, T cell subsets and NK cells. Key research interests are the immunology of infectious disease including severe bacterial infections, Zika virus and Chikungunya virus. Other projects focus on autoimmune disease including the role of the microbiota in rheumatoid arthritis and autoimmune immunotoxicity in cancer immunotherapy. He serves as editor for a number of journals and has roles with a number of funding organisations.